- Journal List >
- Br J Cancer >
- Volume 106(10); May 8, 2012
Volume 106(10); May 8, 2012
Editorial
Towards individualisation of treatment in endometrial cancer
S E Taylor, J A Green
Br J Cancer. 2012 May 8; 106(10): 1581–1582. Published online 2012 May 8. doi: 10.1038/bjc.2012.140
- PMCID:
- PMC3349249
Free in PMC on 2013/05/08
Short Communication
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
C M M Prado, T Bekaii-Saab, L A Doyle, S Shrestha, S Ghosh, V E Baracos, M B Sawyer
Br J Cancer. 2012 May 8; 106(10): 1583–1586. Published online 2012 April 17. doi: 10.1038/bjc.2012.144
- PMCID:
- PMC3349178
Free in PMC on 2013/05/08
Clinical Studies
Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α
S Patil, R A Figlin, T E Hutson, M D Michaelson, S Negrier, S T Kim, X Huang, R J Motzer
Br J Cancer. 2012 May 8; 106(10): 1587–1590. Published online 2012 May 8. doi: 10.1038/bjc.2012.149
- PMCID:
- PMC3349250
Free in PMC on 2013/05/08
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer
J-C Jo, J-L Lee, M-H Ryu, H M Chang, M Kim, H J Lee, H-S Kim, J-G Shin, T-W Kim, Y-K Kang
Br J Cancer. 2012 May 8; 106(10): 1591–1597. Published online 2012 April 19. doi: 10.1038/bjc.2012.143
- PMCID:
- PMC3349177
Free in PMC on 2013/05/08
A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
D S Boss, H Glen, J H Beijnen, M Keesen, R Morrison, B Tait, W Copalu, A Mazur, J Wanders, J P O'Brien, J H M Schellens, T R J Evans
Br J Cancer. 2012 May 8; 106(10): 1598–1604. Published online 2012 April 19. doi: 10.1038/bjc.2012.154
- PMCID:
- PMC3349182
Free in PMC on 2013/05/08
The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform
M-h Chong, Y Zhao, J Wang, X-m Zha, X-a Liu, L-j Ling, Q Du, S Wang
Br J Cancer. 2012 May 8; 106(10): 1605–1610. Published online 2012 April 19. doi: 10.1038/bjc.2012.157
- PMCID:
- PMC3349184
Free in PMC on 2013/05/08
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
M G Wallis, K Clements, O Kearins, G Ball, J Macartney, G M Lawrence
Br J Cancer. 2012 May 8; 106(10): 1611–1617. Published online 2012 April 19. doi: 10.1038/bjc.2012.151
- PMCID:
- PMC3349181
Free in PMC on 2013/05/08
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
K Ribi, J Aldridge, K-A Phillips, A Thompson, V Harvey, B Thürlimann, F Cardoso, O Pagani, A S Coates, A Goldhirsch, K N Price, R D Gelber, J Bernhard
Br J Cancer. 2012 May 8; 106(10): 1618–1625. Published online 2012 April 24. doi: 10.1038/bjc.2012.156
- PMCID:
- PMC3349183
Free in PMC on 2013/05/08
Mould-active compared with fluconazole prophylaxis to prevent invasive fungal
diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell
transplantation: a systematic review and meta-analysis of randomised controlled
trials
M C Ethier, M Science, J Beyene, M Briel, T Lehrnbecher, L Sung
Br J Cancer. 2012 May 8; 106(10): 1626–1637. Published online 2012 May 8. doi: 10.1038/bjc.2012.147
- PMCID:
- PMC3349180
Free in PMC on 2013/05/08
Translational Therapeutics
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
L C J Baker, J K R Boult, S Walker-Samuel, Y-L Chung, Y Jamin, M Ashcroft, S P Robinson
Br J Cancer. 2012 May 8; 106(10): 1638–1647. Published online 2012 April 12. doi: 10.1038/bjc.2012.131
- PMCID:
- PMC3349173
Free in PMC on 2013/05/08
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells
T Troiani, L Vecchione, E Martinelli, A Capasso, S Costantino, L P Ciuffreda, F Morgillo, D Vitagliano, E D'Aiuto, R De Palma, S Tejpar, E Van Cutsem, M De Lorenzi, M Caraglia, L Berrino, F Ciardiello
Br J Cancer. 2012 May 8; 106(10): 1648–1659. Published online 2012 May 8. doi: 10.1038/bjc.2012.129
- PMCID:
- PMC3349172
Free in PMC on 2013/05/08
The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction
G Descamps, P Gomez-Bougie, J Tamburini, A Green, D Bouscary, S Maïga, P Moreau, S Le Gouill, C Pellat-Deceunynck, M Amiot
Br J Cancer. 2012 May 8; 106(10): 1660–1667. Published online 2012 April 17. doi: 10.1038/bjc.2012.139
- PMCID:
- PMC3349175
Free in PMC on 2013/05/08
Molecular Diagnostics
Expression of Forkhead box P3 in tumour cells causes immunoregulatory function
of signet ring cell carcinoma of the stomach
M Yoshii, H Tanaka, M Ohira, K Muguruma, T Iwauchi, T Lee, K Sakurai, N Kubo, M Yashiro, T Sawada, K Hirakawa
Br J Cancer. 2012 May 8; 106(10): 1668–1674. Published online 2012 April 19. doi: 10.1038/bjc.2012.141
- PMCID:
- PMC3349176
Free in PMC on 2013/05/08
Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay
T Osako, T Iwase, K Kimura, K Masumura, R Horii, F Akiyama
Br J Cancer. 2012 May 8; 106(10): 1675–1681. Published online 2012 April 24. doi: 10.1038/bjc.2012.168
- PMCID:
- PMC3349186
Free in PMC on 2013/05/08
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
C Krakstad, J Trovik, E Wik, I B Engelsen, H M J Werner, E Birkeland, M B Raeder, A M Øyan, I M Stefansson, K H Kalland, L A Akslen, H B Salvesen
Br J Cancer. 2012 May 8; 106(10): 1682–1688. Published online 2012 March 13. doi: 10.1038/bjc.2012.91
- PMCID:
- PMC3349187
Free in PMC on 2013/05/08
The differential effects of statins on the metastatic behaviour of prostate cancer
M Brown, C Hart, T Tawadros, V Ramani, V Sangar, M Lau, N Clarke
Br J Cancer. 2012 May 8; 106(10): 1689–1696. Published online 2012 April 24. doi: 10.1038/bjc.2012.138
- PMCID:
- PMC3349174
Free in PMC on 2013/05/08
Genetics and Genomics
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien, E Sawyer, A Hall, R Wilkinson, D Easton, The UKGPCS Collaborators, D Goldgar, R Eeles, Z Kote-Jarai
Br J Cancer. 2012 May 8; 106(10): 1697–1701. Published online 2012 April 19. doi: 10.1038/bjc.2012.146
- PMCID:
- PMC3349179
PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells
E Pestereva, S Kanakasabai, J J Bright
Br J Cancer. 2012 May 8; 106(10): 1702–1712. Published online 2012 April 24. doi: 10.1038/bjc.2012.161
- PMCID:
- PMC3349185
Free in PMC on 2013/05/08